What is the recommended breast cancer surveillance for BRCA mutation carriers, including MRI and mammography, and the rationale?

• A. Annual breast MRI is recommended starting in late teens/early 20s, with annual mammography typically beginning around age 30 to optimize detection in dense breast tissue.
• B. Mammography only starting around age 50.
• C. MRI only starting at age 60.
• D. No special surveillance beyond routine screening.

Answer: (A)

In BRCA mutation carriers, breast cancer risk is high and cancers tend to occur at younger ages, so surveillance must use highly sensitive imaging from an early stage. MRI, especially with contrast, is markedly more sensitive than mammography for detecting cancers in dense, young breasts. Starting annual breast MRI in the late teens or early 20s catches cancers at smaller sizes when they are more treatable. Complementing this with annual mammography beginning around age 30 adds the ability to detect calcifications and cancers that MRI might miss in dense tissue, improving overall detection.

Choosing MRI alone or delaying surveillance would miss cancers that can arise early in these high-risk individuals, and starting screening too late reduces the chance of catching cancers early. The combination of early MRI surveillance plus mammography around the age where breast density begins to decrease provides the best balance of early detection and practical considerations.